CARDIOTOXICITY
Clinical trials for CARDIOTOXICITY explained in plain language.
Never miss a new study
Get alerted when new CARDIOTOXICITY trials appear
Sign up with your email to follow new studies for CARDIOTOXICITY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Exercise may shield hearts of breast cancer survivors
Disease control Not yet recruitingThis study tests whether a 16-week supervised exercise program can help repair heart damage caused by breast cancer treatments like chemotherapy. Researchers will enroll 44 women who finished cardiotoxic therapy 6 to 12 months ago. Half will do twice-weekly strength and aerobic s…
Matched conditions: CARDIOTOXICITY
Phase: NA • Sponsor: University of Castilla-La Mancha • Aim: Disease control
Last updated May 11, 2026 20:40 UTC
-
AI vs. MRI: the race to spot Chemo's hidden heart damage
Diagnosis Not yet recruitingThis study aims to see if new artificial intelligence (AI) software can improve heart scans for people receiving chemotherapy. Researchers will compare the AI-enhanced scans to standard heart scans and MRI images in 120 patients. The goal is to find out if the AI can more accurat…
Matched conditions: CARDIOTOXICITY
Sponsor: The Royal Wolverhampton Hospitals NHS Trust • Aim: Diagnosis
Last updated Apr 17, 2026 16:11 UTC
-
Heart shield: new trial tests drug to stop chemo side effects
Prevention Not yet recruitingThis study tests whether a drug called sotagliflozin can prevent heart, muscle, and fat damage caused by a common type of chemotherapy (anthracycline) in people with newly diagnosed lymphoma. About 60 adults will receive either the drug or a placebo during their first round of ch…
Matched conditions: CARDIOTOXICITY
Phase: PHASE2 • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Prevention
Last updated May 17, 2026 02:01 UTC
-
New study aims to predict heart risks in stem cell patients
Knowledge-focused Not yet recruitingThis study will follow 400 people receiving stem cell transplants for blood cancers to better understand why some develop serious heart problems. Researchers will use heart scans, blood tests, and other monitoring to find early warning signs. The goal is to improve follow-up care…
Matched conditions: CARDIOTOXICITY
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated May 17, 2026 02:02 UTC
-
New study tracks hidden heart risks in breast cancer therapy
Knowledge-focused Not yet recruitingThis observational study follows 100 women with early-stage breast cancer who are receiving standard chemotherapy or anti-HER2 therapy. Researchers want to see if certain heart tests and blood markers can detect early signs of heart damage before it becomes serious. Participants …
Matched conditions: CARDIOTOXICITY
Sponsor: Fatih GURLER • Aim: Knowledge-focused
Last updated May 15, 2026 11:54 UTC
-
New computer tool aims to guide heart care for cancer survivors
Knowledge-focused Not yet recruitingThis study is testing a new computer-based decision aid designed to help cancer survivors and their heart doctors. The tool, accessed through electronic health records, aims to improve decisions about heart-protective medications and monitoring tests. Researchers want to see if b…
Matched conditions: CARDIOTOXICITY
Sponsor: Medical College of Wisconsin • Aim: Knowledge-focused
Last updated Apr 07, 2026 14:37 UTC